Validating Predictive Models and Biomarkers of Radiotherapy Toxicity to Reduce Side-Effects and Improve Quality of Life in Cancer Survivors

The purpose of this international study is to try to predict which patients are more likely to have side effects from radiotherapy

News

REQUITE meeting in Maastricht

We can look back on a productive Congress in Maastricht.  The fourth Annual REQUITE meeting was held on Monday 11th July (afternoon) and Tuesday 12th July followed by the Radiogenomics consortium meeting on Wednesday 13th July.The work of the past year and the first research results were presented and analyzed and new actionpoints were made. New upcoming projects were also presented. There was plenty of opportunity for engaging discussions and to exchange knowledge.

 

11-13 July 2016: Annual REQUITE and Radiogenomics Consortium Meeting in Maastricht.

The 4th Annual REQUITE Meeting and the 8th Annual Meeting of the Radiogenomics Consortium will take place from 11 - 13 July, 2016 in Maastricht, the Netherlands and is hosted by MAASTRO-Clinic.

Many of the researchers involved in the REQUITE project are also part of the Radiogenomics consortium. A good reason to combine both yearly meetings at one moment of the year in the same venue, giving the involved people the opportunity to attend both meetings.

Poster based on first prostate cancer patients in Requite project at DEGRO 2016!

At the DEGRO 2016: The German Society for Radiation oncology meeting in cooperation with the Austrian society for radiation oncology, radiobiology and medical Radiophysics (ÖGRO) in Mannheim, Germany from 16-19 June 2016 a REQUITE poster was shown: "Akute Nebenwirkungen bei Standardfraktionierung versus Hypofraktionierung, Ergebnisse der Auswertung von Arzt- und Patientenangaben".  The researchers looked at the side effects in prostate cancer patients receiving standard fractionation doses versus higher fraction

Older news

Recruitment

Breast
1873
Lung
403
Prostate
1682

Events

HEC 2016

This is one conference joining the activities of four scientific disciplines: 
Medical Informatics (MIE2016), Medical Biometry, Bioinformatics, Epidemiology and Health Data Management.
It will serve as an important scientific forum for the exchange of new ideas and applications to strengthen health sciences on a national and international level. http://www.hec2016.eu/

Dates: 
Sunday, 28 August, 2016 to Friday, 2 September, 2016
Location: 
Ludwig-Maximilians-University Munich
Geschwister-Scholl-Platz 1
80539 Munich
Germany
DE

2016 World Cancer Congress

The World Cancer Congress is run by the Union for International Cancer Control (UICC) and takes place every two years in a different country, always hosted by a UICC member organisation. The conference is aligned with UICC's purpose statement of uniting the cancer community, to reduce the global cancer burden, to promote greater equity and to integrate cancer into the world's health and development agenda. 

Dates: 
Monday, 31 October, 2016 to Thursday, 3 November, 2016
Location: 
Palais des congrès
2 Place de la Porte Maillot
75017 Paris
France
FR

NCRI Cancer Conference

The NCRI Cancer Conference showcases the latest basic, translational and clinical cancer research. It brings researchers together to share ideas and develop collaborations. The National Cancer Research Institute is a UK-wide partnership between research funders working together to make faster progress against cancer.

Dates: 
Sunday, 6 November, 2016 to Wednesday, 9 November, 2016
Location: 
The BT Convention Centre
Kings Dock, Waterfront
L3 4FP Liverpool
United Kingdom
GB